LOGIN  |  REGISTER
Cue Biopharma

Health Catalyst to Participate in Upcoming Investor Conferences

August 21, 2025 | Last Trade: US$3.12 0.06 1.80

SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:

  • The Cantor Global Healthcare Conference, being held in New York, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, September 3, 2025 at 9:10am ET.
  • The Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat with Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, September 4, 2025 at 1:30pm ET. The webcast link will be available online at https://ir.healthcatalyst.com.
  • The Morgan Stanley 23rd Annual Global Healthcare Conference, being held in New York, including a fireside chat with Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Tuesday, September 9, 2025 at 11:30am ET.

About Health Catalyst

Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.

Health Catalyst Investor Relations Contact:

Matt Hopper
SVP of Finance and Head of Investor Relations
+1 (855) 309-6800
This email address is being protected from spambots. You need JavaScript enabled to view it.

Health Catalyst Media Contact:

Kathryn Mykleseth
Director of PR and Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page